Eugia Steriles, a subsidiary of Aurobindo Pharma, encounters five observations from the US FDA.
On Friday (June 19), Aurobindo Pharma Ltd announced that the United States Food and Drug Administration (US FDA) has completed a pre-approval…
Aurobindo Pharma Set to Initiate ₹800 Crore Buyback at ₹1,475 Per Share Starting April 23
Aurobindo Pharma Ltd announced on Tuesday (April 21) that it has filed the Letter of Offer for its equity share buyback worth up to ₹800 crore…